FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1196-1199 October 10, 2002 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Small, K. M. PubMed Citation

Congestive heart failure is the eventual outcome of diverse myocardial insults, including postischemic remodeling, primary cardiomyopathies, and infections.¹ Even for specific forms of myocardial injury, it remains difficult to predict the development of congestive heart failure. Racial differences in the incidence of congestive heart failure, reduced penetrance in families with familial cardiomyopathy, and strain-specific effects in animal models all suggest that some of the variation in the general population with regard to susceptibility to heart failure is heritable.² Although early events in the evolution of congestive heart failure are often unknown, the final common pathways are slowly being elucidated. The . . . [Full Text of this Article]

This article has been cited by other articles:

• Barr, D. A. (2005). The Practitioner's Dilemma: Can We Use a Patient's Race To Predict Genetics, Ancestry, and the Expected Outcomes of Treatment?. ANN INTERN MED 143: 809-815 [Abstract] [Full Text]  
• Smith, G. L., Shlipak, M. G., Havranek, E. P., Masoudi, F. A., McClellan, W. M., Foody, J. M., Rathore, S. S., Krumholz, H. M. (2005). Race and Renal Impairment in Heart Failure: Mortality in Blacks Versus Whites. Circulation 111: 1270-1277 [Abstract] [Full Text]  
• Oudit, G. Y., Crackower, M. A., Eriksson, U., Sarao, R., Kozieradzki, I., Sasaki, T., Irie-Sasaki, J., Gidrewicz, D., Rybin, V. O., Wada, T., Steinberg, S. F., Backx, P. H., Penninger, J. M. (2003). Phosphoinositide 3-Kinase {gamma}-Deficient Mice Are Protected From Isoproterenol-Induced Heart Failure. Circulation 108: 2147-2152 [Abstract] [Full Text]  
• Cooper, R. S., Kaufman, J. S., Ward, R. (2003). Race and Genomics. NEJM 348: 1166-1170 [Full Text]  
• (2002). Adrenergic-Receptor Polymorphisms May Predict CHF Risk. Journal Watch Cardiology 2002: 4-4 [Full Text]